The Institute of Medical Biology at Chinese Academy of Medical Sciences (IMBCAMS) said on Sunday that it has started a second phase human trial of a potential COVID-19 vaccine. As of now, more than a dozen vaccines are in different stages of human trials globally. However, none of the vaccines have passed late-stage phase 3 clinical trials, a step required for getting regulatory approval for sale. The institute further says that it expects to use a plant dedicated to producing a coronavirus vaccine this year to prepare for China`s future vaccine supplies. Instead of working on 1 COVID-19 vaccine, the world is working on ~ 100 vaccines at the same time.

Source: dna June 21, 2020 13:07 UTC